World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
24337
World Ranking
12368
National Ranking
667

Peter J. Wild publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter J. Wild sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 535 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter J. Wild D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter J. Wild sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter J. Wild is affiliated with the Frankfurt Institute for Advanced Studies in Germany. Their research primarily revolves around medicine and biochemistry, genetics, and molecular biology, with a significant focus on oncology and cancer-related fields.

The scientist's work covers a broad spectrum of subfields within medical science, including pulmonary and respiratory medicine, surgery, oncology, molecular biology, and cancer research. Their main topics of investigation include prostate cancer treatment and research, cancer genomics and diagnostics, prostate cancer diagnosis and treatment, radiomics and machine learning in medical imaging, bladder and urothelial cancer treatments, cholangiocarcinoma and gallbladder cancer studies, and cancer immunotherapy and biomarkers.

Peter J. Wild has contributed to several frequent publication venues, such as:

  • Die Pathologie
  • Cancers
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Frontiers in Oncology
  • Scientific Reports

Among their recent papers are:

  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer, 2021, JAMA Oncology
  • Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis, 2020, Cancer Cell
  • Strategies to enable large-scale proteomics for reproducible research, 2020, Nature Communications
  • The proteogenomic subtypes of acute myeloid leukemia, 2022, Cancer Cell
  • AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer, 2020, The Journal of Experimental Medicine

Frequent co-authors collaborating with Peter J. Wild include:

  • Henning Reis
  • Katrin Bankov
  • Jens Köllermann
  • Felix K.-H. Chun
  • Melanie Demes

Best Publications

  • Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

    Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis

  • WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.

    Christoph Wissmann;Peter Johannes Wild;Simone Kaiser;Stefan Roepcke

  • Automated Gleason grading of prostate cancer tissue microarrays via deep learning

    Eirini Arvaniti;Eirini Arvaniti;Kim S. Fricker;Michael Moret;Niels Rupp

  • Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells

    Cornel Fraefel;Song Song;Filip Lim;Phung Lang

  • Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

    Ernst Holler;Gerhard Rogler;Hans H Herfarth;Julia Brenmoehl

  • Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

    David N. Church;David N. Church;Ellen Stelloo;Remi A. Nout;Nadejda Valtcheva

  • Reliable detection of subclonal single-nucleotide variants in tumour cell populations

    Moritz Gerstung;Christian Beisel;Markus Rechsteiner;Peter Wild

  • Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

    Xiangpeng Dai;Wenjian Gan;Xiaoning Li;Xiaoning Li;Shangqian Wang

  • Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors : a systematic expression analysis

    Alexander Hamm;Juergen Veeck;Nuran Bektas;Peter J Wild

  • Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

    Ramin Massoumi;Silke Kuphal;Claus Hellerbrand;Bodo Haas

  • TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer

    Anna C. Groner;Laura Cato;Jonas de Tribolet-Hardy;Tiziano Bernasocchi

  • Serotonin promotes tumor growth in human hepatocellular cancer

    Christopher Soll;Jae Hwi Jang;Marc-Oliver Riener;Wolfgang Moritz

  • Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

    Jean Philippe P Theurillat;Jean Philippe P Theurillat;Namrata D. Udeshi;Wesley J. Errington;Wesley J. Errington;Tanya Svinkina

  • Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas

    Marc-Oliver Riener;Frank Stenner;Heike Liewen;Christopher Soll

  • Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

    Maximilian Burger;Madelon N.M. van der Aa;Johanna M.M. van Oers;Anke Brinkmann

  • Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

    Igor Cima;Ralph Schiess;Peter Wild;Martin Kaelin

  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.

    Emmanouil Fokas;Emmanouil Fokas;Anke Schlenska-Lange;Bülent Polat;Gunther Klautke

  • Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.

    Eva Klopocki;Glen Kristiansen;Peter J. Wild;Irina Klaman

  • Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice

    Joachim Albers;Michal Rajski;Désirée Schönenberger;Sabine Harlander

  • Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

    B. Becker;G. Multhoff;B. Farkas;P.-J. Wild

Frequent Co-Authors

Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Holger Moch
Holger Moch University of Zurich
Glen Kristiansen
Glen Kristiansen University Hospital Bonn
Edgar Dahl
Edgar Dahl RWTH Aachen University
Silke Gillessen
Silke Gillessen Universita della Svizzera Italiana
Anja-Katrin Bosserhoff
Anja-Katrin Bosserhoff University of Erlangen-Nuremberg
Torben F. Ørntoft
Torben F. Ørntoft Aarhus University
Mathias Ackermann
Mathias Ackermann University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career opportunities in medicine often goes beyond the traditional path of becoming a doctor. There are flexible online programs for those interested in healthcare roles that blend patient care, mental health, and management. For example, aspiring nurses can jumpstart their careers through a 9 month lpn program, which allows them to join the workforce quickly and start gaining hands-on experience.

For those passionate about mental health, online pmhnp programs can equip students to become Psychiatric Mental Health Nurse Practitioners and address the growing demand for mental health professionals.

If you are interested in the business and management side of healthcare, consider a bachelors in health administration. This degree prepares students for leadership roles in various healthcare organizations. There are also programs designed for cost-conscious students, such as the cheapest master's in healthcare administration, which can propel you to senior management positions without excessive tuition fees.

These related online degrees and career pathways offer diverse options for making a difference in healthcare, even if you opt for a non-traditional route.

Best Scientists Citing Peter J. Wild

Trending Scientists

Recently Published Articles